Stroke Preclinical Trials Consortia (U01)

The summary for the Stroke Preclinical Trials Consortia (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Stroke Preclinical Trials Consortia (U01): The National Institute of Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network (CSN) have developed a partnership to facilitate the development of multi-institutional, multidisciplinary collaborations to address the pre-clinical translational challenges in stroke research and to conduct pre-clinical trials. Applications must have a consortium structure comprised of at least 3 participating laboratories at different institutions and a coordinating center that is responsible for data coordination, site and steering committee communication. Each preclinical site should have two (2) stroke models (species) available with one model common to all sites within the consortium. A steering committee of external advisors, NIH staff and consortium investigators will be responsible for protocol development. The NINDS intends to commit approximately $1.5 million in total costs in FY 2008 for this announcement to support a total of 2 meritorious applications. A consortium may request a project period of up to four years and a budget for direct costs up to $500,000 in each year. The CSN is currently funding one Canadian consortium at the level of $1.10 million per year for a 2 year period with the opportunity to extend for an additional 2 year period. This funding opportunity will use the NIH cooperative agreement research grant (U01) award mechanism. Eligible organizations include Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Eligible agencies of the Federal government; Faith-based or community based organizations. Eligible principal investigators include any individual with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Applicants may submit more than one application, provided they are scientifically distinct. Competing renewal (formerly competing continuation ) and resubmission applications will not be accepted under this FOA. At this time, it is not known if this FOA will be reissued. More than one PD/PI, or multiple PDs/PIs, may be designated on the application.